This editorial reviews a recently published guideline on management of irritable bowel syndrome. The guideline illustrates problems arising from the quality of clinical trials used in systematic reviews and the potential impact of the inherent weaknesses of those trials on rating the strength of evidence and the resulting recommendations.
- American college of gastroenterology
- Irritable bowel syndrome
ASJC Scopus subject areas
- Pharmacology (medical)